Quarterly report pursuant to Section 13 or 15(d)

Nature of Operations and Summary of Significant Accounting and Reporting Policies - Schedule of Dilutive Securities Excluded from Computation (Details)

v3.20.4
Nature of Operations and Summary of Significant Accounting and Reporting Policies - Schedule of Dilutive Securities Excluded from Computation (Details) - shares
6 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Antidilutive securities excluded from computation of earnings per share 4,335,690 12,352
Stock Options [Member]    
Antidilutive securities excluded from computation of earnings per share 60 60
Stock Warrants [Member]    
Antidilutive securities excluded from computation of earnings per share 135,724 1,975
Unvested Restricted Stock [Member]    
Antidilutive securities excluded from computation of earnings per share 59 117
Convertible Debt [Member]    
Antidilutive securities excluded from computation of earnings per share 4,199,847 10,200